<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01938755</url>
  </required_header>
  <id_info>
    <org_study_id>odu52</org_study_id>
    <nct_id>NCT01938755</nct_id>
  </id_info>
  <brief_title>Hyperbaric Levobupivacaine for Spinal Anaesthesia</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>T.C. ORDU ÜNİVERSİTESİ</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>T.C. ORDU ÜNİVERSİTESİ</source>
  <brief_summary>
    <textblock>
      Spinal anaesthesia also called spinal block or sub-arachnoid block (SAB), is a form of
      regional anaesthesia involving injection of a local anaesthetic into the subarachnoid space,
      generally through a fine needle.

      There is no generic hyperbaric form of levobupivacaine currently available so we aimed in
      this study that to find the appropriate concentration of the levobupivacaine which achieves
      unilateral spinal anesthesia. The potential benefits of this type of anesthesia are less
      motor blockade and urinary retention, decrease in hospital stay. Therefore, it seems to be
      suitable for outpatient anesthesia.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Actual">January 2014</completion_date>
  <primary_completion_date type="Actual">January 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>degree of motor blockade</measure>
    <time_frame>until dissolve of motor blockade</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">73</enrollment>
  <condition>This Study Was Focused on Selective Spinal Anesthesia for Lower Extremity Surgery in Order to Achieve Early Mobilization and to Shorten Hospital Stay</condition>
  <arm_group>
    <arm_group_label>levobupivacaine I</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>group that was administered levobupivacaine plus 60mg dextrose</description>
  </arm_group>
  <arm_group>
    <arm_group_label>levobupivacaine II</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>group that was administered levobupivacaine plus 80 mg dextrose</description>
  </arm_group>
  <arm_group>
    <arm_group_label>levobupivacaine III</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>group that was administered levobupivacaine plus 100 mg dextrose</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>levobupivacaine</intervention_name>
    <description>levobupivacaine plus 60 mg dextrose</description>
    <arm_group_label>levobupivacaine I</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>levobupivacaine</intervention_name>
    <description>levobupivacaine plus 80 mg dextrose</description>
    <arm_group_label>levobupivacaine II</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>levobupivacaine</intervention_name>
    <description>levobupivacaine plus 100 mg dextrose</description>
    <arm_group_label>levobupivacaine III</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Approval to participate in the study and spinal anesthesia

          -  American society of anesthesia (ASA) I,II physical status

          -  Scheduled for lower extremity surgery

        Exclusion Criteria:

          -  Refuse to participate in the study

          -  American society of anesthesia (ASA)III, IV physical status

          -  Hypersensitivity to local anesthetics

          -  Emergency surgery

          -  Chronic pain treatment

          -  Peripheral neuropathy

          -  Severe systemic disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Anestesia and Reanimation Dept.; Ordu University Education and Research Hospital</name>
      <address>
        <city>Ordu</city>
        <zip>52100</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 5, 2013</study_first_submitted>
  <study_first_submitted_qc>September 5, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 10, 2013</study_first_posted>
  <last_update_submitted>April 3, 2017</last_update_submitted>
  <last_update_submitted_qc>April 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>T.C. ORDU ÜNİVERSİTESİ</investigator_affiliation>
    <investigator_full_name>özgür yağan</investigator_full_name>
    <investigator_title>Özgür Yağan</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Levobupivacaine</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

